SCHEDULE 13G/A: Suvretta Capital Management and Affiliates Disclose Significant Passive Stake in Immatics N.V.

Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen have filed an amended Schedule 13G, disclosing their beneficial ownership of 7.5% and 6.7% respectively, in Immatics N.V.'s ordinary shares as of March 31, 2025.

Summary

• Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Immatics N.V.
• Suvretta Capital Management, LLC and Aaron Cowen each beneficially own 9,135,029 ordinary shares of Immatics N.V., representing 7.5% of the class.
• Averill Master Fund, Ltd. beneficially owns 8,091,288 ordinary shares of Immatics N.V., representing 6.7% of the class.
• All reported shares are held with shared voting and shared dispositive power by the respective reporting persons.
• The securities are directly owned by advisory clients of Suvretta Capital Management, LLC, with Averill Master Fund, Ltd. being one client that beneficially owns over 5% of the shares.
• Aaron Cowen is identified as the control person for Suvretta Capital Management, LLC.
• The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of Immatics N.V.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, providing neutral information without explicit positive or negative sentiment regarding the issuer's performance or outlook.

Risks

• The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating concerns about potential activist investor actions.

Industry Context

This filing indicates significant institutional investment in Immatics N.V., a biotechnology company. Such disclosures are common for publicly traded companies and reflect the investment decisions of large funds and individuals in the market.

Related Party Transactions

• Aaron Cowen is the control person for Suvretta Capital Management, LLC.
• Averill Master Fund, Ltd. is an advisory client of Suvretta Capital Management, LLC and directly owns a significant portion of the reported shares.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can be viewed positively as a vote of confidence or negatively if it signals potential future selling pressure. The passive nature of the investment, as certified, suggests no immediate intent to influence company control.
• Management: Awareness of significant institutional holders, though the passive nature of the investment indicates no immediate challenge to current management or strategy.

Key Dates

Keywords

Immatics N.V., Suvretta Capital Management, Averill Master Fund, Aaron Cowen, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investment, Ordinary Shares, Biotechnology, Investment Adviser